Celsion Corporation Stock News

Preclinical results demonstrate safe and efficient immune response with vaccine development showing promise of neutralizing activity for a range of variants

Celsion (CLSN) has priced and closed its registered direct offering of convertible redeemable preferred stock.The company entered into a securities purchase agreement with

LAWRENCEVILLE, N.J., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, today

LAWRENCEVILLE, N.J., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, today

Celsion Corp (CLSN) shares closed today at 1.8% above its 52 week low of $0.52, giving the company a market cap of $45M. The stock is currently down 2.8% year-to-date, down 35.9% over the past 12 months, and down 88.1% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 13.2% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.5. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -46.8% The company's stock price performance over the past 12 months beats the peer average by -7.2% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Celsion Corp (CLSN) shares closed today at 1.2% above its 52 week low of $0.52, giving the company a market cap of $45M. The stock is currently down 2.3% year-to-date, down 33.4% over the past 12 months, and down 88.0% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 1.7%. Trading Activity Trading volume this week was 12.6% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.5. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -28.0% The company's stock price performance over the past 12 months beats the peer average by -5.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Celsion Corp (CLSN) shares closed 1.4% lower than its previous 52 week low, giving the company a market cap of $54M. The stock is currently down 12.2% year-to-date, down 15.1% over the past 12 months, and down 87.6% over the past five years. This week, the Dow Jones Industrial Average rose 1.6%, and the S&P 500 rose 2.3%. Trading Activity Trading volume this week was 28.2% lower than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -47.4% The company's stock price performance over the past 12 months beats the peer average by -47.6% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

AT&T Inc. (NYSE:T) with the stream of 0.36% also noticed, India Celsion Corporation (NASDAQ:CLSN) encountered a rapid change of -2.62% in the last hour of Thursdays trading session. AT&T Inc. The post Investors Alert (ATR Analysis): AT&T Inc. (NYSE:T), Celsion Corporation (NASDAQ:CLSN) appeared first on Stocks Equity .

Sundial Growers Inc. (NASDAQ:SNDL) with the stream of -0.37% also noticed, India Celsion Corporation (NASDAQ:CLSN) encountered a rapid change of 2.87% in the last hour of Wednesdays trading session. Sundial The post Hair-raising Facts to Know: Sundial Growers Inc. (NASDAQ:SNDL), Celsion Corporation (NASDAQ:CLSN) appeared first on Stocks Equity .

State Street Corp bought a new position in shares of Celsion Co. (NASDAQ:CLSN) in the 2nd quarter, Holdings Channel reports. The institutional investor bought 214,568 shares of the biotechnology companys stock, valued at approximately $273,000. A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the []

Celsion Co. (NASDAQ:CLSN) was the target of a significant drop in short interest in November. As of November 15th, there was short interest totalling 1,720,000 shares, a drop of 27.1% from the October 31st total of 2,360,000 shares. Based on an average trading volume of 961,300 shares, the short-interest ratio is currently 1.8 days. A []

Celsion Corporation’s GEN-1 IL-12 Program in Advanced Ovarian Cancer to be Featured in Poster Presentation

Celsion Corporation s GEN-1 IL-12 Program in Ad vanced Ovarian Cancer to be Featured in Poster Presentation

Celsion Corporation 's GEN-1 IL-12 Program in Ad vanced Ovarian Cancer to be Featured in Poster Presentation

Sesen Bio, Inc. (SESN) with the stream of -0.92% also noticed, India Celsion Corporation (CLSN) encountered a rapid change of -5.25% in the last hour of trading session. Sesen Bio, The post Volume Sizzler: Sesen Bio, Inc. (NASDAQ:SESN), Celsion Corporation (NASDAQ:CLSN) appeared first on Stocks Equity .